SUBSTITUTED 3-PYRIDYL THIOPHENES AS C17,20 LYASE INHIBITORS

Details for Australian Patent Application No. 2002334729 (hide)

Owner BAYER CORPORATION

Inventors BIERER, Donald; ACHEBE, Furahi; McCLURE, Andrea, C.

Pub. Number AU-A-2002334729

PCT Number PCT/US02/30981

PCT Pub. Number WO2003/027105

Priority 60/324,993 26.09.01 US

Filing date 26 September 2002

Wipo publication date 7 April 2003

International Classifications

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 031/4427 - containing further heterocyclic ring systems

A61P 035/00 Antineoplastic agents

C07D 333/00 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/324,993 26.09.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002334729

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334730-SUBSTITUTED 3-PYRIDYL IMIDAZOLES AS C17,20 LYASE INHIBITORS

2002334728-SUBSTITUTED 3-PYRIDYL PYRROLES AND 3-PYRIDYL PYRAZOLES AS C17,20 LYASE INHIBITORS